National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Elbasvir 50mg/100mg grazoprevir (EBR/GZR)(Zepatier®) is indicated for the treatment of genotypes 1 and 4 chronic HCV infection in patients with Child-Turcotte-Pugh score A (CTPA).

Rapid Review

Commenced Completed Outcome
10/08/2016 13/10/2016 Full Pharmacoeconomic Evaluation Not Recommended